-
Pediatric Glioblastoma with Persistent STAG2 Mutation
Dataset
EGAD00001006202
-
Raw RNA-seq data for clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial
Dataset
EGAD00001006205
-
Single-cell RNA-sequencing reveals that glioblastoma recapitulates a normal neurodevetlopmental hierarchy
Dataset
EGAD00001006206
-
Merged single-cell RNA-seq data for 22 Hodgkin lymphomas and 5 reactive lymph nodes
Dataset
EGAD00001006221
-
Identification of gene mutations and fusion genes in patients with Sézary Syndrome
Study
EGAS00001001706
-
Prognostic relevance of microenvironmental factors CD163 and CD8 combined with EZH2 and chromosome 18 gain in a validation cohort of follicular lymphoma patients of the Lunenburg Lymphoma Biomarker Consortium
Study
EGAS00001002049
-
MutWP1__CRUK_Grand_Challenge_Mutographs_of_Cancer__clear_cell_renal_cell_carcinoma
Study
EGAS00001002608
-
Preferential infiltration of distinct Vγ9δ2 T cells into Glioblastoma multiforme
Study
EGAS00001002790
-
Pan-neuroblastoma analysis reveals age- and signature-associated driver alterations
Study
EGAS00001003931
-
Lindsey E. Jones et al. Patient-derived cells from recurrent tumors that model the evolution of IDH-mutant glioma. Neuro-Oncology Advances, 2020. We established robust, versatile, and well-characterized Patient Derived Cells (PDC) of an IDH1-mutant astrocytoma and an IDH1-mutant oligodendroglioma that represents defined evolutionary stages of chemotherapy-induced hypermutation. The PDCs retain tumor subtype defining features over time as well as classic hallmarks of cancer, including anchorage independent growth and cell immortality. The integrated phylogenies composed of PDCs,single-cell-derived PDCs, patient-derived xenografts, and corresponding spatiotemporal tumor tissue samples also provide new insight into the clonality, evolutionary pattern, and immense mutational load of hypermutated IDH mutant gliomas.
Study
EGAS00001003992
-
The double-hit signature identifies double-hit diffuse large B-cell lymphoma with genetic events cryptic to FISH
Study
EGAS00001004285
-
Clinical relevance of somatic copy-number alterations in plasma circulating tumor DNA from advanced EGFR-mutated NSCLC patients treated with osimertinib
Study
EGAS00001004539
-
OpACIN-neo – A Multicenter Phase 2 Study to identify the Optimal neo-Adjuvant Combination scheme of Ipilimumab and Nivolumab – Whole exome sequencing
Study
EGAS00001004832
-
OpACIN-neo – A Multicenter Phase 2 Study to identify the Optimal neo-Adjuvant Combination scheme of Ipilimumab and Nivolumab – RNA sequencing
Study
EGAS00001004833
-
Assessment of cannabidiol and Δ9-tetrahydrocannabiol in mouse models of medulloblastoma
Study
EGAS00001004963
-
Molecular characterization of Barrett’s esophagus at single cell resolution
Study
EGAS00001005221
-
Sequential single-cell transcriptional and protein marker profiling reveals TIGIT as a marker of CD19 CAR-T cell dysfunction in patients with non-Hodgkin’s lymphoma
Study
EGAS00001005356
-
Genome-wide cell-free DNA termini in patients with cancer
Study
EGAS00001005738
-
Genome-wide cell-free DNA termini in patients with cancer
Study
EGAS00001005747
-
Reprogramming of stroma-derived chemokine networks drives the loss of tissue organization in nodal B cell lymphoma
Study
EGAS00001006986
-
Combination of ribociclib and gemcitabine for the treatment of medulloblastoma
Study
EGAS00001006001
-
early-stage ESCC sequencing study
Study
EGAS00001006126
-
Genome-wide cell-free DNA termini in patients with cancer
Study
EGAS00001006142
-
Multi-organ landscape of therapy-resistant melanoma
Study
EGAS00001006644
-
RNA-seq of DF149 cells – a patient-derived xenograft model of ascites-derived, homologous recombination repair-proficient, high-grade serous ovarian carcinoma – cultured in vitro and isolated after 8 hours treatment with DMSO control (3 x biological replicates) and 2.5 µM CBL0137 (3 x biological replicates)
Study
EGAS00001006662
-
NanoString nCounter® PanCancer IO 360™on anti-PD1/anti-PD1+CTLA4 in patients with metastatic melanoma
Study
EGAS00001006977
-
An IL-1β driven neutrophil-stromal cell axis fosters a BAFF-rich microenvironment in multiple myeloma
Study
EGAS00001007038
-
ACT-Discover: identifying karyotype heterogeneity in pancreatic cancer evolution using ctDNA
Study
EGAS00001007077
-
Genome-wide cell-free DNA biological patterns in patients with cancer
Study
EGAS00001007400
-
Molecular characterisation of paediatric PDX cells before and after 3D RASTRUM bioprinting
Study
EGAS00001008220
-
Mapping the lineage-retained antigen landscape in neuroblastoma
Study
EGAS00001008445
-
Epigenetic subtypes of neuroblastoma - ChIPseq
Dataset
EGAD00001006285
-
Epigenetic subtypes of neuroblastoma - RNAseq
Dataset
EGAD00001006286
-
Survival Benefit and Genetic Profile of Pemetrexed as Initial Chemotherapy in Selected Chinese Patients with Advanced Lung Adenocarcinoma
Dataset
EGAD00001006287
-
ctDNA monitoring using patient-specific sequencing and integration of variant reads - Breast cohort
Dataset
EGAD00001006293
-
Therapeutic vulnerabilities in the DNA damage response for the treatment of ATRX mutant neuroblastoma
Dataset
EGAD00001006294
-
Genomic and transcriptomic data of glioma specimens
Dataset
EGAD00001006299
-
Genomic characterization (through whole-exome sequencing) of bone marrow clonal plasma cells before and after VRD treatment from multiple myeloma patients.
Dataset
EGAD00001006302
-
SF10679
Dataset
EGAD00001006312
-
The Transcriptional Landscape of SHH Medulloblastoma
Dataset
EGAD00001006305
-
Clinical Outcomes by Tumor Mutational Burden and Inflammatory Gene Expression With Combined Nivolumab and Ipilimumab or Monotherapy in Advanced Melanoma_CM67-RNASeq
Dataset
EGAD00001006306
-
Clinical Outcomes by Tumor Mutational Burden and Inflammatory Gene Expression With Combined Nivolumab and Ipilimumab or Monotherapy in Advanced Melanoma - CM066-WES
Dataset
EGAD00001006309
-
SF11940
Dataset
EGAD00001006311
-
SF11310
Dataset
EGAD00001006313
-
SF12374
Dataset
EGAD00001006315
-
SF10619
Dataset
EGAD00001006316
-
SF4007
Dataset
EGAD00001006317
-
SF10207
Dataset
EGAD00001006319
-
SF4454
Dataset
EGAD00001006318
-
Single-cell Full Transcriptome RNA sequencing
Dataset
EGAD00001006325